These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19928558)

  • 1. [Choice of maintenance dialysis therapy in patients with CKD stage 5D].
    Honda H; Akizawa T
    Nihon Jinzo Gakkai Shi; 2009; 51(7):857-9. PubMed ID: 19928558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T; Yamamoto H
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual renal function and dialysis modality: is it really beneficial to preserve residual renal function in dialysis patients?
    Canaud B; Chenine L; Leray-Moragués H; Wiesen H; Tetta C
    Nephrology (Carlton); 2006 Aug; 11(4):292-6. PubMed ID: 16889567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients treated with automated peritoneal dialysis: effects of selection of patients.
    Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):40-8. PubMed ID: 21196611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standard methods of peritoneal dialysis (PD) and standard peritoneal dialysis solutions in the future in Japan].
    Nakamoto H
    Nihon Jinzo Gakkai Shi; 2009; 51(7):864-74. PubMed ID: 19928560
    [No Abstract]   [Full Text] [Related]  

  • 6. Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study.
    Chung AW; Yang HH; Kim JM; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
    Nephrol Dial Transplant; 2010 Dec; 25(12):4031-41. PubMed ID: 20466676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational guide to reducing fracture risk in dialysis patients.
    Toussaint ND; Elder GJ; Kerr PG
    Semin Dial; 2010; 23(1):43-54. PubMed ID: 20331818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nephrocare project: referral, patient case-mix, follow-up and quality of renal care in Nordic renal centres.
    Bergrem H; Gøransson LG; Asmundsson P; Feldt-Rasmussen B; Grønhagen-Riska C; Westberg G
    Scand J Urol Nephrol; 2009; 43(4):319-24. PubMed ID: 19333821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Active treatment of renal disease in Finland].
    Stenman S; Grönhagen-Riska C
    Duodecim; 1995; 111(15):1497-504. PubMed ID: 9244706
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.
    Johnson ES; Thorp ML; Platt RW; Smith DH
    Am J Kidney Dis; 2008 Oct; 52(4):653-60. PubMed ID: 18585833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of modalities of blood purification therapy for various diseases].
    Suzuki T; Ota K
    Nihon Rinsho; 1991 Dec; 49 Suppl():655-62. PubMed ID: 1808332
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of renal artery stenosis in dialysis patients.
    Dwyer JP; Greco BA; Lewis JB
    Semin Dial; 2009; 22(5):519-23. PubMed ID: 19558627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["A golden decade" for kidney medicine. Gene therapy is expected to result in a new break through].
    Aurell M
    Lakartidningen; 1998 Jun; 95(23):2660-4. PubMed ID: 9656615
    [No Abstract]   [Full Text] [Related]  

  • 16. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalographic changes in renal failure and their alteration after dialysis procedures.
    Sawhney BB; Anand SK; Chugh KS; Chopra JS
    Neurol India; 1975 Dec; 23(4):176-81. PubMed ID: 1219495
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal replacement therapy in elderly patients: peritoneal dialysis.
    Catizone L; Malacarne F; Bortot A; Annaloro M; Russo G; Barillà A; Storari A
    J Nephrol; 2010; 23 Suppl 15():S90-7. PubMed ID: 20872376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5.
    Murtagh FE; Marsh JE; Donohoe P; Ekbal NJ; Sheerin NS; Harris FE
    Nephrol Dial Transplant; 2007 Jul; 22(7):1955-62. PubMed ID: 17412702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.